With the vigorous development of Chinese medicine industry, it is imperative to strengthen cooperation with foreign pharmaceutical enterprises.

Astrazeneca, one of the world's top five international pharmaceutical companies, has incorporated China into the global drug research and development system as a key market for increased investment in personnel and projects.